Mazoteras-Pardo Victoria, Becerro-De-Bengoa-Vallejo Ricardo, Losa-Iglesias Marta Elena, López-López Daniel, Rodríguez-Sanz David, Casado-Hernández Israel, Calvo-Lobo Cesar, Palomo-López Patricia
School of Nursing, Physiotherapy, and Podiatry, Universidad Complutense de Madrid, Madrid, Spain.
Faculty of Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain.
J Med Internet Res. 2019 Dec 2;21(12):e14686. doi: 10.2196/14686.
Hypertension is considered as a main risk factor for chronic kidney disease development and progression. Thus, the control and evaluation of this disease with new software and devices are especially important in patients who suffer from chronic kidney disease.
This study aimed to validate the QardioArm mobile device, which is used for blood pressure (BP) self-measurement in patients who suffer from chronic kidney disease, by following the European Society of Hypertension International Protocol 2 (ESH-IP2) guidelines.
A validation study was carried out by following the ESH-IP2 guidelines. A sample of 33 patients with chronic kidney disease self-measured their BP by using the QardioArm and Omron M3 Intellisense devices. Heart rate (HR), diastolic BP, and systolic BP were measured.
The QardioArm fulfilled the ESH-IP2 validation criteria in patients who suffered from chronic kidney disease.
Thus, this study is considered as the first validation using a wireless upper arm oscillometric device connected to an app to measure BP and HR meeting the ESH-IP2 requirements in patients who suffer from chronic kidney disease. New validation studies following the ESH-IP2 guidelines should be carried out using different BP devices in patients with specific diseases.
高血压被认为是慢性肾脏病发生和进展的主要危险因素。因此,对于慢性肾脏病患者而言,利用新软件和设备对该疾病进行控制和评估尤为重要。
本研究旨在依据欧洲高血压学会国际方案2(ESH-IP2)指南,验证用于慢性肾脏病患者自测血压的QardioArm移动设备。
按照ESH-IP2指南开展一项验证研究。33例慢性肾脏病患者的样本使用QardioArm和欧姆龙M3 Intellisense设备自测血压。测量心率(HR)、舒张压和收缩压。
QardioArm符合慢性肾脏病患者的ESH-IP2验证标准。
因此,本研究被视为首次使用连接应用程序的无线上臂示波装置测量血压和心率并符合ESH-IP2要求的慢性肾脏病患者验证研究。应遵循ESH-IP2指南,针对特定疾病患者使用不同血压设备开展新的验证研究。